Quince Therapeutics, Inc. (QNCX) — Tangible Net Worth Ratio
Quince Therapeutics, Inc. (QNCX) has a Tangible Net Worth Ratio of -332.7% as of March 2026. This metric is calculated by deducting intangible assets ($67.82 Million) from net assets ($15.67 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See QNCX book value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Quince Therapeutics, Inc. Tangible Net Worth Ratio (2018–2024)
This chart shows how Quince Therapeutics, Inc.'s Tangible Net Worth Ratio has changed across 7 annual periods from 2018 to 2024. As of March 2026, the ratio stands at -332.7%, reflecting net assets of $15.67 Million with intangible assets of $67.82 Million USD. Also explore QNCX shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Quince Therapeutics, Inc. (2018–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Quince Therapeutics, Inc. from 2018 to 2024, covering 7 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Quince Therapeutics, Inc. market capitalisation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -99.2% | $30.15 Million | $60.05 Million | $114.48 Million | ▼ -124.3 pp |
| 2023 | 25.2% | $85.08 Million | $63.67 Million | $180.20 Million | ▼ -69.0 pp |
| 2022 | 94.1% | $100.59 Million | $5.90 Million | $103.91 Million | ▼ -5.9 pp |
| 2021 | 100.0% | $118.59 Million | $0.00 | $133.23 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $172.26 Million | $0.00 | $189.47 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $115.48 Million | $0.00 | $124.37 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $71.42 Million | $0.00 | $72.88 Million | — |